Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.6/5
Hologic Inc (HOLX US)
Watchlist
Contact IR
47
Analysis
Health Care
•
United States
Hologic, Inc. is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Volpara Health Technologies
•
13 Mar 2024 07:43
Volpara Health (VHT AU): Scheme Vote on 12 April
The scheme vote will get up as the offer is attractive vs. historical trading ranges. At the last close and for the 21 May payment, the gross...
Arun George
Follow
408 Views
Share
bullish
•
Hologic Inc
•
11 Feb 2024 07:00
Hologic Inc: Fortifying Market Position Through Innovation & Strategic Acquisitions! - Major Drivers
Hologic reported its fiscal Q1 2024 results, demonstrating strong financial performance with total revenue reaching $1.01 billion, above the high...
Baptista Research
Follow
350 Views
Share
bullish
•
Hologic Inc
•
12 Jan 2024 07:08
Hologic Inc.: Anticipating Continued Growth Across Divisions - What's the Outlook for 2024? - Major Drivers
Hologic, Inc. managed to exceed analyst expectations in terms of revenue as well as earnings, concluding Q4 with total revenue at $945.3 million...
Baptista Research
Follow
409 Views
Share
bullish
•
Hologic Inc
•
03 Oct 2023 06:00
Hologic Inc.: Decoding the Reasons Behind the Double-Digit Molecular Growth! - Major Drivers
Hologic, Inc. exceeded analyst expectations in terms of revenue as well as earnings. Non-GAAP earnings per share were $0.93 and the total revenue...
Baptista Research
Follow
264 Views
Share
bullish
•
Hologic Inc
•
04 Jul 2023 14:23
Hologic Inc.: 3 Key Drivers & Strategic Priorities Driving Growth – Financial Forecasts
Hologic managed to exceed the revenue expectations as well as the earnings expectations of Wall Street. The company's financial results surpassed...
Baptista Research
Follow
330 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x